Surgery Partners, Inc. (NASDAQ:SGRY) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 21.1% during the 2nd quarter, Holdings Channel.com reports. The firm owned 15,504 shares of the company’s stock after acquiring an additional 2,703 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Surgery Partners were worth $369,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of SGRY. Janus Henderson Group PLC boosted its stake in shares of Surgery Partners by 7,987.1% in the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after buying an additional 2,473,282 shares during the last quarter. Iron Triangle Partners LP acquired a new position in Surgery Partners in the fourth quarter valued at approximately $33,415,000. Norges Bank purchased a new stake in Surgery Partners in the 4th quarter worth approximately $25,765,000. Vanguard Group Inc. grew its stake in shares of Surgery Partners by 10.4% during the 4th quarter. Vanguard Group Inc. now owns 7,417,609 shares of the company’s stock worth $237,289,000 after purchasing an additional 698,845 shares during the period. Finally, Wellington Management Group LLP increased its holdings in shares of Surgery Partners by 3.7% during the 4th quarter. Wellington Management Group LLP now owns 8,318,176 shares of the company’s stock valued at $266,098,000 after purchasing an additional 295,476 shares in the last quarter.

Surgery Partners Price Performance

NASDAQ:SGRY opened at $30.18 on Friday. The firm has a market cap of $3.84 billion, a P/E ratio of 43.58, a price-to-earnings-growth ratio of 2.33 and a beta of 2.76. The stock has a 50 day moving average of $28.79 and a two-hundred day moving average of $27.62. Surgery Partners, Inc. has a 12 month low of $22.05 and a 12 month high of $36.92. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. The firm had revenue of $762.10 million during the quarter, compared to the consensus estimate of $735.94 million. During the same period in the prior year, the company earned $0.25 EPS. The firm’s revenue was up 14.2% compared to the same quarter last year. On average, analysts expect that Surgery Partners, Inc. will post 0.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

SGRY has been the topic of a number of recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a report on Monday, August 19th. Royal Bank of Canada reissued an “outperform” rating and set a $49.00 target price on shares of Surgery Partners in a research note on Wednesday, August 7th. Benchmark restated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. StockNews.com downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Finally, Macquarie began coverage on Surgery Partners in a research note on Friday, June 28th. They set an “outperform” rating and a $31.00 target price for the company. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $39.86.

Insider Transactions at Surgery Partners

In related news, insider Danielle Burkhalter sold 6,000 shares of the company’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $26.39, for a total transaction of $158,340.00. Following the completion of the sale, the insider now owns 30,354 shares of the company’s stock, valued at approximately $801,042.06. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 2.30% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.